The U.S. Food and Drug Administration (FDA) recently approved Epizyme, Inc’s tazemetostat (TAZVERIK) for the treatment of adult and pediatric patients with metastatic or…
The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to Global Blood Therapeutics’ voxelotor (Oxbryta), a treatment for adults and pediatric patients…
Innovative study designs examine implementation and generate new knowledge. Takeaways: Some organizations struggle to meet Magnet® nurse research requirements. Many research efforts result in…
The Food and Drug Administration (FDA) has recently granted accelerated approval to BeiGene’s mantle cell lymphoma (MCL) oral therapy, zanubritinib (BRUKINSA). (more…)
The American Heart Association (AHA) recently held its 2019 Scientific Sessions in Philadelphia PA. The sessions covered many topics, but one of the most…
The American College of Sports Medicine (ACSM) recently released new guidelines for exercise prescriptions while patients are undergoing cancer treatment. (more…)
The U.S. Food and Drug Administration (FDA) recently approved Epizyme, Inc’s tazemetostat (TAZVERIK) for the treatment of adult and pediatric patients with…
The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to Global Blood Therapeutics’ voxelotor (Oxbryta), a treatment for adults and…
Innovative study designs examine implementation and generate new knowledge. Takeaways: Some organizations struggle to meet Magnet® nurse research requirements. Many research efforts…
The Food and Drug Administration (FDA) has recently granted accelerated approval to BeiGene’s mantle cell lymphoma (MCL) oral therapy, zanubritinib (BRUKINSA). (more…)
The American College of Sports Medicine (ACSM) recently released new guidelines for exercise prescriptions while patients are undergoing cancer treatment. (more…)